Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Kidney International|May 15, 2017
Are sensitized patients better off with a desensitization transplant or waiting on dialysis?Philip A Clayton, P Toby Coates
Clinical Journal of the American Society of Nephrology : CJASN|July 23, 2016
Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant RecipientsSunil V Badve, Elaine M Pascoe, Michael Burke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2012
End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry casesWen Tang, Stephen P McDonald, Carmel M Hawley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2014
End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry casesAndrew Mallett, Wen Tang, Philip A Clayton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2013
The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New ZealandWen Tang, Bhadran Bose, Stephen P McDonald, et al.
Kidney International|December 21, 2012
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal diseaseWen Tang, Stephen P McDonald, Carmel M Hawley, et al.
Nephrology (Carlton, Vic.)|November 28, 2023
Assessing survival post-kidney transplantation in Australia: A multivariable prediction modelLachlan C McMichael, Aarti Gulyani, Philip A Clayton
Transplant International : Official Journal of the European Society for Organ Transplantation|June 19, 2019
Risk factors for and outcomes of delayed graft function in live donor kidney transplantation - a retrospective studyManohar Reddy Mogulla, Shantanu Bhattacharjya, Philip A Clayton
Pageof 19